Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68071-2471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-2471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)
Chemical structure of cyclobenzaprine hydrochloride showing its molecular framework with labeled functional groups and the hydrochloride salt component.*
FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 02)

FDA Label Image

Pdp (68071 2471 1)

Pdp (68071 2471 1)
Cyclobenzaprine hydrochloride 7.5 mg film-coated tablets packaging label by NuCare Pharmaceuticals, Inc. The label states the quantity as 15 tablets, describes the tablet as round yellow with "U" debossed on one side and "6" on the other. It includes NDC 68071-2471-1, storage instructions at controlled temperature 68-77°F, and warnings to keep out of reach of children. Manufacturer is 3 Unicharm Laboratories Ltd, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.